Mechanistically, SHH can induce epithelial–mesenchymal transition (EMT), matrix metalloproteinase 9 (MMP-9) activity and tumor lymphangiogenesis through the PI3K/Akt pathway, thereby promoting tumor progression and LN metastasis. Here, AKT1 is linked to neoplasm.